EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, CTSO: Cytosorbents Cor

24 Oct 25 15:47
LAST:

0.8502

CHANGE:
 0.01		OPEN:
0.8490		HIGH:
0.8598		ASK:
7.7000		VOLUME:
13.4K
CHG(%):
0.97		PREV:
0.8420		LOW:
0.8490		BID:
5.4500		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
24 Oct 250.84900.85980.84900.850213.4K
23 Oct 250.84200.86410.82970.842025.3K
22 Oct 250.83000.86420.80100.850184.8K
21 Oct 250.85500.88000.82000.8282125.1K
20 Oct 250.89250.90000.84000.850086.8K
17 Oct 250.91000.91980.88000.885592.6K
16 Oct 250.91870.91990.90500.905541.6K
15 Oct 250.94000.94000.91400.916033.7K
14 Oct 250.91000.92950.91000.921838.4K
13 Oct 250.92000.98570.92000.930059.4K

COMPANY PROFILE

Name:Cytosorbents Cor
About:Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. The company's flagship product is CytoSorb, an extracorporeal blood purification cartridge for the treatment of massive inflammation, organ failure, cardiothoracic surgery to remove antithrombotic drugs and inflammatory mediators that can lead to postoperative complications, such as severe bleeding, shock, failure to wean from mechanical ventilation, sepsis, and multiple organ failure; DrugSorb-ATR, an antithrombotic removal system; VetResQ, a broad-spectrum blood purification adsorber for the treatment of septic shock, toxic shock syndrome, toxin-mediated diseases, pancreatitis, trauma, liver failure, heat stroke, and lung injury in animals; PuriFi, an advanced hemoperfusion pump for blood purification therapies; and ECOS-300CY, an ex vivo organ perfusion system to preserve or improve the health and quality of harvested solid organs to be transplanted. In addition, it develops HemoDefend-BGA, a blood purification technology platform to reduce anti-A and anti-B antibodies in plasma and whole blood. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.
Sector:Healthcare
Address:305 College Road East, Princeton, NJ, United States, 08540
Website:https://www.cytosorbents.com
CUSIP:58404X107
CIK:0001175151
ISIN:US23283X2062
FIGI:BBG000C3P8V0
LEI:549300VI8WO8GK5QK793

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.840.7%
MA10:0.883.3%
MA20:0.917.3%
MA50:0.9410.4%
MA100:1.0017.8%
MA200:1.0118.3%
STO9:19.68 
STO14:12.81 
RSI14:31.92 
WPR14:-85.01 
MTM14:-0.10
ROC14:-0.10 
ATR:0.05 
Week High:0.928.2%
Week Low:0.806.1%
Month High:1.0220.0%
Month Low:0.8018.3%
Year High:1.6189.4%
Year Low:0.7119.7%
Volatility:24.67 

RECENT SPLITS

Date Ratio
05 Dec 20141-25